You have 9 free searches left this month | for more free features.

pegaspargase

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extranodal NK/T-cell Lymphoma Trial in Beijing (Gemcitabine, Pegaspargase, Etoposide)

Recruiting
  • Extranodal NK/T-cell Lymphoma
  • Beijing, China
    Beijing Tongren Hospital
Jun 2, 2021

Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Guangzhou (Pegaspargase, Anti-PD-1 mAb, Definitive intensity-modulated

Not yet recruiting
  • Extranodal NK/T-cell Lymphoma, Nasal Type
  • Pegaspargase
  • +2 more
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Dec 16, 2020

Extranodal NK/T-cell Lymphoma Trial (Basiliximab, Pegaspargase)

Not yet recruiting
  • Extranodal NK/T-cell Lymphoma
  • (no location specified)
Apr 6, 2020

Leukemia Trial (cyclophosphamide, cytarabine, daunorubicin HCl)

Active, not recruiting
  • Leukemia
  • (no location specified)
Aug 16, 2021

Acute Lymphoblastic Leukemia, ALL, Childhood, ALL Trial in Chicago (Ruxolitinib, Cyclophosphamide, Cytarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
Sep 14, 2021

Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)

Recruiting
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Dec 16, 2020

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)

Unknown status
  • Acute Lymphoblastic Leukemia
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 18, 2019

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type, Early-stage, High-Risk Cancer Trial in Beijing (Anti-PD-1 mAb,

Recruiting
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • +2 more
  • Anti-PD-1 monoclonal antibody
  • +4 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Feb 23, 2022

Lymphoma Trial in Changsha (pegaspargase, Gemcitabine, Oxaliplatin)

Unknown status
  • Lymphoma
  • pegaspargase
  • +8 more
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jan 25, 2020

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Aug 20, 2021

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Kansas City (Velcade, Methotrexate, Methotrexate / Hydrocortisone

Terminated
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Kansas City, Missouri
    Children's Mercy Hospital
Jul 23, 2019

B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Ph-Like Acute Lymphoblastic Leukemia
  • Duarte, California
    City of Hope Medical Center
Jul 26, 2022

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in United

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Calaspargase Pegol-mknl
  • +14 more
  • Birmingham, Alabama
  • +26 more
Apr 2, 2021

Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide

Active, not recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Birmingham, Alabama
  • +173 more
Nov 16, 2021

Lymphoma, Extranodal NK-T-Cell Trial in GuangZhou (gemcitabine, oxaliplatin, pegaspargase)

Terminated
  • Lymphoma, Extranodal NK-T-Cell
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 8, 2018

Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in

Terminated
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Los Angeles, California
  • +27 more
Oct 5, 2020

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Asparaginase Erwinia chrysanthemi
  • +15 more
  • Birmingham, Alabama
  • +219 more
Aug 24, 2022

Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Sydney, Australia
  • +114 more
Jul 6, 2021

Lymphoma, Extranodal NK-T-Cell Trial in GuangZhou (Gemcitabine, Oxaliplatin, Pegaspargase)

Terminated
  • Lymphoma, Extranodal NK-T-Cell
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 8, 2018

Leukemia Trial in Worldwide (biological, drug, procedure)

Unknown status
  • Leukemia
  • anti-thymocyte globulin
  • +21 more
  • Boston, Massachusetts
  • +12 more
Jul 29, 2019

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +21 more
  • Birmingham, Alabama
  • +218 more
Jul 15, 2022